Torthaí cuardaigh - Gurdeep Parmar

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study de réir Alexander M. Lesokhin, Richard LeBlanc, Meletios Α. Dimopoulos, Marcelo Capra, Carmelo Carlo‐Stella, Lionel Karlin, Jean‐François Castilloux, Peter A. Forsberg, Gurdeep Parmar, Axel Tosikyan, Luděk Pour, Vincent Ribrag, Rossella Ribolla, Al‐Ola Abdallah, Nadia Le Roux, Liyan Dong, Helgi van de Velde, Laurent Mayrargue, Lucie Lépine, Sandrine Macé, Philippe Moreau

Faigh an téacs iomlán Faigh an téacs iomlán

Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Itha... de réir María‐Victoria Mateos, Paula Rodríguez‐Otero, Youngil Koh, Joaquín Martínez‐López, Gurdeep Parmar, H. Miles Prince, Hang Quach, Paz Ribas, Emil Hermansen, Vânia Hungria, Sevgi Kalayoğlu Beşışık, Jin Seok Kim, Xavier Leleu, Valdas Pečeliūnas, Fredrik Schjesvold, Ömür Gökmen Sevindik, Т Е Лаврова, Franck Dubin, Christine Devisme, Lucie Lepine, Sandrine Macé, Mony Morisse, Irene M. Ghobrial

Faigh an téacs iomlán